Treatment with three “targeted” cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis. These risks remain low, but they should be factored in when developing patients’ treatment plans.
Treatment with three “targeted” cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis. These risks remain low, but they should be factored in when developing patients’ treatment plans.